How do you feel after you’ve made an error?Healthcare professionals can feel traumatised when they make an error. Patsy Edwards describes research she conducted into the emotional impact of errors on practitioners and the support they subsequently received.…
Behind the scenes of medicines regulation Sir Michael Rawlins talks about how the MHRA intends to speed up approval of innovative medicines, involve pharmacists in reclassification and address drug shortages and trade in counterfeit medicines.…
Rheumatologists want to see system in place to track efficacy and safety of biosimilar products The British Society of Rheumatology (BSR) wants patients to register with its evidence database to track the efficacy and long-term safety of new biosimilar products.…
US$2bn global innovation fund proposed to tackle antimicrobial resistance A worldwide innovation fund worth up to US$2bn could be set up to encourage the pharmaceutical industry to search for and develop new classes of antibiotics.…
Community pharmacists support new medicine service, research suggestsCommunity pharmacists generally support the new medicine service because they think it will benefit patients, according to new research.…
Paracetamol use linked with cardiovascular risk and other adverse events Researchers have discovered a consistent dose-response relationship between paracetamol use and risk of mortality or cardiovascular, gastrointestinal or renal adverse events.…
Pharmacist’s team wins £50,000 innovation prize for antibiotic prescribing app Microbiology app that assists antibiotic prescribing wins national award.…
WHO appeals for US$1bn to help deliver medical aid The World Health Organization is appealing for more than US$1bn to meet the health needs of 21 million people in Syria, Iraq, the Central African Republic and South Sudan.…
Reliable source of oral health information ‘The scientific basis of oral health education’, by R S Levine and C R Stillman-Lowe.…
Safety data prompt calls for a halt on NSAID use in patients with heart disease The use of nonsteroidal anti-inflammatory drugs in patients receiving antithrombotic therapy after myocardial infarction doubles the risk of further heart attacks, researchers find.…